期刊文献+

小剂量甲泼尼龙琥珀酸钠早期治疗手足口病疗效观察 被引量:3

Clinical observation on early interference treatment for hand-foot-and-mouth disease with small doses of methylprednisolone
在线阅读 下载PDF
导出
摘要 目的:观察小剂量甲泼尼龙琥珀酸钠早期干预治疗小儿手足口病的疗效。方法:将1 800例手足口病患儿随机分为治疗组950例和对照组850例,对照组给予常规退热及对症治疗,治疗组在对照组治疗的基础上加用甲泼尼龙琥珀酸钠1~2 mg.kg-1.d-1静脉滴注,对2组临床治疗结果进行比较。结果:治疗组患儿的退热时间、皮肤疱疹愈合时间、肢体抖动停止时间、睡眠易惊停止时间均较对照组显著缩短(P<0.01)。结论:小剂量甲泼尼龙琥珀酸钠早期干预治疗小儿手足口病优于常规对症治疗,值得临床推广应用。 Objective:To observe the efficacy of early interference treatment for hand-foot-and-mouth disease with small doses methylprednisolone.Methods:One thousand eight hundred hand-foot-and-mouth disease patients were randomly divided into two groups.The treatment group(n=950) was treated with symptomatic treatment and intravenous drip treatment with methylprednisolone 1-2 mg·kg-1·d-1,the control group(n=850) was treated with symptomatic treatment and conventional treatment for abatement of fever.To investigate the therapeutic effect of the two groups of clinical treatment.Results:The treatment efficacy in the treatment group was higher than in the control group(P0.01),comparing the time to allaying a fever,stopping body shaking,stopping frightened during sleep in two groups.Conclusions:The therapeutic effect in the treatment group with small doses of methylprednisolone early interference treatment was superiorer than in the control group with conventional symptomatic treatment,it was well worth clinical popularizing and application.
出处 《蚌埠医学院学报》 CAS 2010年第12期1270-1271,共2页 Journal of Bengbu Medical College
关键词 手足口病 甲泼尼龙琥珀酸钠 早期干预 hand-foot-and-mouth disease methylprednisolone early intervention
作者简介 李传杰(1972-),男,主治医帅.
  • 相关文献

参考文献7

二级参考文献29

  • 1杨建东,李家顺,贾连顺,钱列,曹师峰,邵将,陈宣维.大剂量甲基强的松龙对大鼠急性脊髓损伤预防保护作用的研究[J].中国脊柱脊髓杂志,2005,15(1):46-48. 被引量:17
  • 2贾连顺.脊髓损伤药物治疗的研究现状和进展[J].中国脊柱脊髓杂志,1995,5(5):224-226. 被引量:36
  • 3韩汝棠 翟信德.手足口病105例综合报告[J].临床儿科杂志,1998,(6):385-385.
  • 4刘湘云.现代临床病毒学[M].北京:人民军区出版社,1991.356.
  • 5Robert Berkow. The merik manual [M]. Published by menk Researih Laboratories, 16th Ed, 1992: 2180.
  • 6Xu J,Kim GM,Ahmed SH,et al.Glucocorticoid receptormediated suppression of activator protein-1 activation and matrix metalloproteinase expression after spinal cord injury[J].J Neurosci,2001,21(1):92~97.
  • 7Bracken MB,Shepard MJ,Collins WF,et al.A randomized,controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury.Results of the Second National Acute Spinal Cord Injury Study[J].N Engl J Med,1990,322:1405~1411.
  • 8Bracken MB,Shepard MJ,Holford TR,et al.Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury.Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial.National Acute Spinal Cord Injury Study[J].JAMA,1997,277:1597~1604.
  • 9Ji B,Li M,Budel S,et al.Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury[J].Eur J Neurosci,2005,22(3):587~594.
  • 10Yip CC,Chng NW,Au Eong KG,et al.Low-dose intravenous methylprednisolone or conservative treatment in the management of traumatic optic neuropathy[J].Eur J Ophthalmol,2002,2(4):309~314.

共引文献185

同被引文献33

引证文献3

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部